Envoy Medical earnings were -$23.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest COCH earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$7.3M, up 38.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, COCH reported annual earnings of -$29.9M, with 87.8% growth.
Envoy Medical (NASDAQ: COCH) reported Q3 2024 earnings per share (EPS) of -$0.37, up 384.62% year over year. Total COCH earnings for the quarter were -$7.34 million. In the same quarter last year, Envoy Medical's earnings per share (EPS) was $0.13.
As of the last Envoy Medical earnings report, Envoy Medical is currently losing money. Envoy Medical's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$21.06 million, a 42.17% decrease year over year.
What was COCH's earnings growth in the past year?
As of Envoy Medical's earnings date in Q1 2025, Envoy Medical's earnings has grown year over year. COCH earnings in the past year totalled -$23.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.